Biotech Incentives Bill Spurs Constitutional Worries

RALEIGH — An economic incentives bill eligible for consideration in the General Assembly’s short session next year, known as the Life Sciences Development Act, would establish a private company to make taxpayer-funded loans of up to $30 million apiece to biotechnology and pharmacy startups in North Carolina.